Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia.

ABSTRACT:

SUBMITTER: Barth BM 

PROVIDER: S-EPMC6737412 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature